Australian Pharmaceutical Industries (API)
Australian Pharmaceutical Industries Ltd. engages in the manufacturing and distributing pharmaceutical, health, and beauty products. It operates through the following segments: Pharmacy Distribution, Retailing, and Manufacturing. The Pharmacy Distribution segment includes distribution of pharmaceutical and medical products to pharmacies and provides retail services to pharmacy customers. The Retailing segment involves in the purchase and sale of health, beauty, and lifestyle products within the retail industry. The Manufacturing segment comprises of manufacturing and owning right of pharmaceutical medicines and consumer toiletries. The company was founded in 1910 and is headquartered in Camellia, Australia.
|Market Price at 18-01-2018
|Price to Earnings Ratio
|Return on Equity (ROE)
Blog posts that reference Australian Pharmaceutical Industries:
Thursday, June 20, 2013
With interest rates at historical lows and further cuts likely, investors chasing income shouldn’t overlook high quality listed stocks paying consistently high dividends. Australian tax laws – which refund the difference between the (30%) tax a company pays (on fully franked dividends) and your own personal tax rate - contributes to the attractiveness of owning stocks paying a high dividend yield.
But focusing on dividend yield - the dividend per share as a percentage of the share price - in isolation can be a trap, especially if a company’s current earnings are unsustainable and start deteriorating. Remember that if you do rely on income from your share portfolio, high dividends don’t always equate to good investments.
Wednesday, October 24, 2012
Today when you login to Skaffold, navigate to the Skaffold Score Evaluate screen for AMP Limited, Coca-Cola Amatil, Westfield, Rio Tinto or Westpac (they’re just a few companies whose Skaffold Score changed last night). You’ll notice the 2012 columns look a little different. Skaffold’s interim Scores ensure you have access to the latest reported financial information for every company. Skaffold’s Scores are based on past reported results and do not take into consideration future value forecasts. The Scores are completely objective and manufactured independently of human intervention and personal opinion. Continue reading the see a summary of the companies that reported at 30 June and their resulting interim Skaffold Scores.
Wednesday, February 01, 2012
For investors, the two main places to put your money are shares and property. With both these markets well off their highs, 2012 is shaping as a good year to invest in either - or both. With this in mind, Money magazine enlisted experts to come up with a top 50 list for both shares and property.
Skaffold.com is an exciting new stock-selection application that rates all ASX-listed companies from A1 to C The Skaffold Score benchmark rating allows investors to focus on the best companies, avoiding those with doubtful fundamentals that may be wealth destroying. Skaffold.com has identified 50 value-for-money stocks for you to consider.